Showing 1141-1150 of 1211 results for "".
- GenSight Biologics Reports Findings From Studies Highlighting Benefits From Lumevoq Compared to LHON Natural Historyhttps://modernod.com/news/gensight-biologics-reports-findings-from-studies-highlighting-benefits-from-lumevoq-compared-to-lhon-natural-history/2477163/GenSight Biologics reported results from the REALITY registry study and an analysis of REVERSE and RESCUE phase 3 data, which further highlight the poor prognosis for patients with loss of vision due to Leber Hereditary Optic Neuropathy (LHON) associated with the ND4 mutation. The results
- Watching for Radiation Harm After Interventional Procedureshttps://modernod.com/news/watching-for-radiation-harm-after-interventional-procedures/2477165/Interventional procedures can expose interventionalists and nearby staff to high doses of radiation, and this can lead to radiation-associated lens opacities, said Madan Rehani, PhD, director of Global Outreach for Radiation Protection at Massachusetts General Hospital in Boston, in a Medscape
- Smartphone App Spots Undiagnosed Symptomatic Dry Eye, Helps Identify Risk Factorshttps://modernod.com/news/smartphone-app-spots-undiagnosed-symptomatic-dry-eye-helps-identify-risk-factors/2477144/A smartphone app can identify people with undiagnosed symptomatic dry eye and identify factors linked with the condition, according to a new crowd-sourced study, Reuters reported. “We identified risk factors possibly associated with undiagnosed symptomatic dry eye, including younger
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosahttps://modernod.com/news/proqr-receives-orphan-drug-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa/2477112/ProQR Therapeutics announced that it received orphan drug designation (ODD) from the FDA for QR-1123, a first-in-class investigational antisense oligonucleotide designed to address the underlying cause of vision loss associated with autosomal dominant retinitis pigmentosa (adRP) due to the P23H m
- Eversight Awarded $50,000 to Investigate Cell Expansion to Address Global Cornea Shortagehttps://modernod.com/news/eversight-awarded-50000-to-investigate-cell-expansion-to-address-global-cornea-shortage/2477085/Eversight announced the Eye Bank Association of America (EBAA) awarded a $50,000 High Impact Research Grant to the organization and its research partners to investigate cell expansion aiming to mitigate the global shortage of surgical quality donor corneas available for transplantation. Mo
- Largest Study of Chinese Americans Uncovers Unique Risk Factors for Visual Impairmenthttps://modernod.com/news/largest-study-of-chinese-americans-uncovers-unique-risk-factors-for-visual-impairment/2477019/CHA Hollywood Presbyterian Medical Center (CHA HPMC) announced publication of a study by Rohit Varma, MD, MPH, director of its Southern California Eye Institute, assessing risk factors for vision impairment in Chinese Americans. The largest study on Chinese Americans to date, “Factors Associated
- Alcon Celebrates World Sight Day, Strengthens Commitment to Enhancing Global Access to Eye Carehttps://modernod.com/news/alcon-celebrates-world-sight-day-strengthens-commitment-to-enhancing-global-access-to-eye-care/2476983/Thousands of Alcon associates worldwide are participating in activities to support the advancement of eye health in honor of World Sight Day. To celebrate the occasion, the company announced a theme for the upcoming year, “Alcon: The Official Sponsor of 20/20,” which is designed to highlight its
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t
- MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferenceshttps://modernod.com/news/meiragtx-to-present-clinical-data-from-phase-1-2-trial-of-aav-rpe65-at-upcoming-scientific-conferences/2476861/MeiraGTx Holdings announced that clinical data updates from the company’s phase 1/2 trial of AAV-RPE65 will be presented at two upcoming medical meetings. The phase 1/2 open-label, multicenter, dose-finding trial evaluated AAV-RPE65 in patients with retinal dystrophy associated with diseas